SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
Show
20
per page| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Malladi Drugs & Pharmaceuticals Limited | Pharmaceuticals, Biotechnology and Life Sciences | Asia | Targets set | Medium | 3 | Feb 27, 2025 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year - Long-Term Status Targets set Net-Zero Status Targets set Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Asia Organization Type Corporate Location India Company Size Medium Target Statement Overall Net-Zero Target: Malladi Drugs & Pharmaceuticals Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Malladi Drugs & Pharmaceuticals Limited commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by FY203… Stakeholders Shreya Sistla Managing Director, Malladi Group ESG Senior Officer - Strategic Procurement & Sustainable development Head Strategic Sourcing | |||||||
Show
20
per pageTurn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.